“Even the longest book is read and was written one word at a time.”
― Mokokoma Mokhonoana ―
Graphics are edited by the #cn1699 team.
Follow our pages for more #inspiration.
All #graphics are #free to #share.
Images used are owned by their respective owners.
Visit us : https://social.cn1699.com/";
MedTech World Deepens Asia Collaboration with Cross-Border Tour to Qianhai
On 2 July, MedTech World successfully concluded its Hong Kong Roadshow 2025 in partnership with NovaX. The final leg of the roadshow included a high-impact cross-border delegation tour to Shenzhen’s Qianhai Cooperation Zone. This marked another important step in connecting Asia’s innovation ecosystems with the global MedTech community.
Reflecting on the week of programming, Dr. Dylan Attard, CEO of MedTech World, said:
... moreMedTech World Deepens Asia Collaboration with Cross-Border Tour to Qianhai
On 2 July, MedTech World successfully concluded its Hong Kong Roadshow 2025 in partnership with NovaX. The final leg of the roadshow included a high-impact cross-border delegation tour to Shenzhen’s Qianhai Cooperation Zone. This marked another important step in connecting Asia’s innovation ecosystems with the global MedTech community.
Reflecting on the week of programming, Dr. Dylan Attard, CEO of MedTech World, said:
“The Hong Kong Roadshow 2025 exceeded expectations. From the quality of the discussions to the energy on the ground in both Hong Kong and Shenzhen, it’s clear that this region is ready to become a global hub for MedTech. We’re incredibly grateful to our partners, and we look forward to continuing to connect Asia with the rest of the world through ongoing dialogue, collaboration, and exchange.”
From Hong Kong to Qianhai: Exploring the Innovation Landscape
In partnership with local government agencies and innovation stakeholders, MedTech World led a diverse group of delegates, including startup founders, investors, researchers, and policy leaders, on a cross-border visit to Shenzhen’s Qianhai district. The delegation visited the Qianhai Exhibition Hall, Qianhai Kerry Centre, and the Qianhai Shenzhen-Hong Kong Youth Innovation Hub, where they witnessed the region’s infrastructure and policy support driving high-growth sectors like MedTech, biotechnology, and digital health.
Following this, the group toured some of the area’s most dynamic health-focused institutions, including WonderCell Therapeutics, the PolyU Qianhai Advanced Technology Innovation Center, and the Qianhai Taikang International Hospital. These visits provided real-world insight into the region’s investment in translational research, medical infrastructure, and commercialization pathways.
Qianhai Seminar: Cross-Border Collaboration in Action
The delegation’s Shenzhen visit culminated with the MedTech World Qianhai Seminar, co-hosted with local authorities and supported by the Hong Kong Talent Engage (HKTE). The seminar opened with welcome remarks from Qianhai leadership, followed by a statement from an HKTEO representative, both underlining the region’s ambition to become a bridge for cross-border innovation.
The keynote session, “Co-Innovating HealthTech: Building Cross-Border Collaborations Between Qianhai and Global MedTech Leaders,” provided a blueprint for how global and regional players can work together. Moderated by Dr. Dylan Attard, CEO of MedTech World, the panel included Christian Espinosa, CEO of Blue Gate Cyber; Sean Yoshikawa, Director–Asia at D-Risk; and Kai Wang, Office Lead at Elsevier Shenzhen. Discussion revolved around opportunities and challenges for cross-border MedTech collaboration in Qianhai, innovation, cybersecurity and patient data protection, risk management, knowledge exchange, and future trends.
During the discussion, Dr. Dylan Attard shared insights on the cultural, regulatory, and operational nuances of international collaboration:
“Cross-border cooperation is no longer optional; it’s essential. We must learn to navigate and respect our cultural differences while focusing on shared goals in MedTech innovation. This tour has shown us how strong partnerships across regions can lead to real, tangible outcomes.”
Continuing the Momentum Toward MedTech Malta 2025
The success of the Hong Kong Roadshow and Qianhai tour signals MedTech World’s continued focus on elevating regional ecosystems through meaningful international engagement. From Hong Kong’s strategic financial access to Shenzhen’s advanced manufacturing and research capabilities, the roadshow highlighted the growing potential of Asia as a global MedTech engine.
With these conversations and collaborations now in motion, all eyes turn to MedTech Malta 2025, scheduled for this November. The Malta event will build on the outcomes of the Asian tour, offering another platform for innovators, investors, regulators, and industry leaders to advance ideas and partnerships on a global scale.
Be Part of What’s Next MedTech Malta 2025 will bring together the conversations sparked in Hong Kong and Shenzhen with global leaders across the sector. Whether you're looking to scale, invest, or build new partnerships, this is where real progress in health innovation takes place. Join us in Valletta this November. To learn more, contact us at hello@med-tech.world.
Looking for Investors? Pitch on Our Stage.
Get in front of the people who matter. From Johnson & Johnson Innovation to some of the most active VCs in MedTech. Our audience is packed with decision-makers looking for the next big thing.
Whether you’re raising your first round or scaling fast, this is your chance to pitch, connect, and accelerate your growth.
Opportunities across the US, Europe, Middle East & Asia
Main Stage: MedTech Malta | 12–14 November 2025
Apply to Pitch: https://shar... moreLooking for Investors? Pitch on Our Stage.
Get in front of the people who matter. From Johnson & Johnson Innovation to some of the most active VCs in MedTech. Our audience is packed with decision-makers looking for the next big thing.
Whether you’re raising your first round or scaling fast, this is your chance to pitch, connect, and accelerate your growth.
Opportunities across the US, Europe, Middle East & Asia
India’s Pharmacovigilance Momentum Takes Center Stage
Event Report: Highlights from the 4th Edition Drug Safety Symposium 2025 – India Chapter
June 25th – 26th, 2025 | Holiday Inn Mumbai International Airport
The 4th Edition Drug Safety Symposium 2025 – India Chapter, hosted by Eminence Business Media, once again proved to be a cornerstone event in the evolving landscape of pharmacovigilance in India. With the theme “Beyond Compliance – Creating a Future-Ready, Globally Aligned PV Ecosystem”,... moreIndia’s Pharmacovigilance Momentum Takes Center Stage
Event Report: Highlights from the 4th Edition Drug Safety Symposium 2025 – India Chapter
June 25th – 26th, 2025 | Holiday Inn Mumbai International Airport
The 4th Edition Drug Safety Symposium 2025 – India Chapter, hosted by Eminence Business Media, once again proved to be a cornerstone event in the evolving landscape of pharmacovigilance in India. With the theme “Beyond Compliance – Creating a Future-Ready, Globally Aligned PV Ecosystem”, the two-day gathering brought together more than 150 pharmacovigilance professionals across the value chain, regulators, global pharma leaders, consultants, technology partners, and PV strategists.
Setting the Tone: Vision, Voice & Velocity
Ms. Guneet Hayer, Managing Director, Eminence Group, opened the symposium with a compelling call to action: for Indian PV leaders to step out of compliance silos and begin architecting scalable, strategic systems that align with global best practices.
This sentiment was reinforced by Dr. Jai Prakash, Senior Principal Scientific Officer and PvPI lead at the Indian Pharmacopoeia Commission, who outlined India’s growing regulatory commitment and global responsibility in drug safety oversight.
From a Regulatory Standpoint: Decoding India’s PV Evolution
Moderated by Dr. Rahul Somani, a panel featuring Dr. Jai Prakash, Dr. Jamal Baig, and Dr. Chetanraj Bhamare took a deep dive into India’s maturing PV regulations. The discussion emphasized the importance of regulatory foresight, system maturity, and data integrity, urging companies to evolve from ‘checklist compliance’ to strategic alignment with global harmonization goals.
Voices that Matter, Conversations that Count
• A fireside chat on GCCs led by Dr. Mukesh Gori, featuring Dr. Retesh Bhumbak, spotlighted India’s transformation from a delivery hub to a strategic global safety engine.
• In the MI-PV Integration Panel, Dr. Rahul Somani, Dr. Anil Pareek, Dr. Sridhar Yeshamaina and Mr. Varun Dua emphasized the necessity of breaking data silos to offer a full-circle view of patient safety.
• Dr. Shubhadeep D. Sinha tackled the nuanced monitoring of biosimilars vs. biologics, focusing on traceability, signal differentiation, and RWE integration.
• With focus on U.S, Dr. Prasad Deshmukh explored Combination Product Safety under FDA regulations and the challenge of dual data attribution.
• Dr. Anju Agarwal addressed the dynamic nature of Risk Management Plans, sharing strategies to embed RMPs and aRMMs into routine PV functions.
• Dr. Chitra Bargaje led a session on PSMF Harmonization, providing a framework to bridge local-global documentation, ownership, and versioning gaps.
• Dr. Siva Kumar Buddha mapped regulatory fragmentation in global PV practices, offering a compliance map to handle RoW variability.
• In a candid session, Dr. Nitu Sinha explored ICSR Grey Zones, including duplicate cases, causality in NIS, and follow-up strategies, offering clarity in otherwise ambiguous areas.
AI, Automation & the Real-World Roadmap: From Hype to Hands-On
AI was not just a buzzword, it was dissected, debated, and demonstrated.
• Dr. Ashish Akar shared real-world use cases of machine learning to reduce operational burden in PV functions.
• Dr. Abhay Chimankar presented a vendor engagement framework to help PV leaders evaluate AI partners with compliance at the forefront.
• Dr. Gopal Muralidharan explored the operational impact of AI on ICSRs and literature monitoring, while also addressing system integration and data governance challenges.
• In a provocative counterpoint, Dr. Graeme Ladds highlighted the power of proven automation, cautioning against overdependence on unvalidated AI systems.
• The segment included live technology demonstration by Navitas Life Sciences, showcasing and an AI-powered literature monitoring platform, led by Dr. Pushpa Basavanapalli and Mr. Subash J.
• To close this thematic track, Souvik Chatterjee delivered a focused session on AI Validation, emphasizing the need for GxP-compliant, audit-ready frameworks to ensure AI tools meet safety-critical standards.
Workshops, Mock Audits & Compliance Tracks: Where Insight Met Action
Dr. Rajendra Kumar Kasi’s interactive session, Operational Excellence in Drug Safety through an Effective QMS, helped participants benchmark their current systems using a PV maturity diagnostic tool, followed by the creation of a quality scorecard tailored to global standards like GVP and FDA 21 CFR Part 11.
A standout feature was the two-part Audit Simulation by Dr. Ahmed Hegazy:
• Part 1 addressed audit expectations in RoW markets, including inspection red flags, affiliate coordination, and proactive risk management.
• Part 2 placed attendees into real-time Mock Audit scenarios, challenging them to respond to regulator queries, documentation requests, and CAPA development on the fly. The exercise concluded with a debrief and the distribution of a customizable Audit Prep Checklist. #EminenceDigitalDetox: A Moment to Pause and Reclaim Balance
The event witnessed a refreshing twist- #EminenceDigitalDetox - encouraging attendees to step away from the screen and reconnect with self and purpose.
At the Digital Detox Tree, delegates left thumbprint pledges in vibrant colors, a symbolic promise to take mindful breaks from digital overload. Meanwhile, the Digital Detox Booth allowed participants to symbolically hand over their phones, turning the spotlight inward on clarity, wellness, and inspiration born in silence.
Looking Ahead: From Dialogue to Direction
The 4th Edition Drug Safety Symposium 2025 – India Chapter wasn’t just another industry event; it was a blueprint for India’s PV transformation. With every session, Eminence Business Media pushed the boundaries of what’s possible, empowering delegates with frameworks, tools, and conversations that will shape the next era of patient safety.
As the PV community looks forward to the 5th Edition Drug Safety Symposium 2026 - Middle East Chapter in January 2026, one thing remains clear: patient safety doesn't pause, and neither do we.
“Everything must be made as simple as possible. But not simpler.”
— Albert Einstein ―
Graphics are edited by the #cn1699 team.
Follow our pages for more #inspiration.
All #graphics are #free to #share.
Images used are owned by their respective owners.
Visit us : https://social.cn1699.com/";
India Health 2025 Returns with Renewed Vigour to Accelerate India's Healthcare Transformation
• 2nd edition to take place from July 11–13, 2025, at the preferred Bharat Mandapam, New Delhi
• Two streams of conference will run parallelly, including one especially curated under the aegis of the Global Medtech Connect
• Above 300 brands and over 8,000 stakeholders expected to converge at the landmark event
New Delhi, June XX, 2025: Building on the momentum of a successful debut, Informa Markets... moreIndia Health 2025 Returns with Renewed Vigour to Accelerate India's Healthcare Transformation
• 2nd edition to take place from July 11–13, 2025, at the preferred Bharat Mandapam, New Delhi
• Two streams of conference will run parallelly, including one especially curated under the aegis of the Global Medtech Connect
• Above 300 brands and over 8,000 stakeholders expected to converge at the landmark event
New Delhi, June XX, 2025: Building on the momentum of a successful debut, Informa Markets in India is all set to host the second edition of the India Health Exhibition from July 11 to 13, 2025, at Bharat Mandapam (formerly Pragati Maidan), New Delhi. Positioned at the forefront of healthcare innovation and collaboration, India Health 2025 will bring together key players from across the healthcare value chain in a format designed to maximize networking, business exchange, and knowledge sharing.
The event, which emerged from the globally acclaimed legacy of WHX- Dubai, is rapidly cementing its place as India's premier healthcare exhibition and conference platform. With India's healthcare sector poised to reach Rs 18.5 Bn by FY 2027, the show's timing aligns perfectly with the industry's urgent demand for inclusive, tech-driven, and scalable healthcare solutions.
A Comprehensive Platform for Industry Collaboration
This year's edition will feature over 300 diverse brands such as Marengo Hospitals, Midmark, Pallakad, Italian Medtech Association, DKS Ortho & Pharmalab with 95% domestic and 5% international representation. The exhibitor categories span the full spectrum of healthcare—including medical equipment and devices, diagnostics, orthopaedics, IT systems, infrastructure, and wellness solutions.
Visitors—expected to exceed 8,000 professionals—will include biomedical engineers, radiologists, pathologists, hospital procurement heads, clinicians, R&D professionals, and medical technology regulators. As part of its mission to democratize access and learning, the India Health Exhibition 2025 will continue to offer expansive show floor featuring innovations, product launches, and an integrated Start-Up and Medical Laboratory Pavilion.
Deep-Dive into Knowledge and Innovation
The event will also feature two different streams of robust knowledge platforms. The specially curated Global Medtech Connect, taking place on July 11 and 12 will feature over 25+ speakers and 100 delegates with subjects such as ‘Navigating Geopolitical Storms: How Indian MedTech Leaders Are Adapting to U.S. Tariff Pressures’; ‘The Role of QMS for MedTech Organizations in India: ISO 13485 and Indian MDR Alignment’; ‘Cultivating a Culture of Excellence in Medical Device Manufacturing and Strengthening India's Medical Device Regulatory System through IMDRF Membership’; and ‘Refurbished Medical Devices: Unlocking Potential Through Regulatory Clarity and Ensuring Patient Safety’, among others.
Parallelly, the show will host over 50+ speakers tackling some of the most critical topics shaping the future of healthcare. From AI-powered diagnostics, preventive genetics, and digital transformation to sustainable practices and entrepreneurial innovation, the themes reflect the evolving priorities of the healthcare ecosystem.
A new addition this year is the B2B Matchmaking App, designed to create structured engagement between buyers and sellers and boost meaningful business interactions. The show will also host dedicated pavilions that spotlight emerging healthcare start-ups and SMEs, furthering the industry's innovation pipeline.
Supporting Industry Growth Amid Policy and Market Shifts
As the healthcare sector navigates economic expansion and policy evolution, India Health 2025 provides a timely platform to respond to industry shifts. The Indian medical tourism market alone is projected to grow from USD 2.89 billion in 2020 to USD 13.42 billion by 2026, while rapid investment in hospital infrastructure, digital tools, and healthcare innovation continues to redefine delivery models. In a fast-moving and competitive exhibition landscape, India Health stands apart by combining deep industry engagement, practical business tools, and strong regional and domestic outreach with the legacy of a coveted international brand.
Elevating India's Role in Global Healthcare
Speaking ahead of the event, Mr. Yogesh Mudras, Managing Director, Informa Markets in India, remarked, "The vision behind the India Health Exhibition has always been to create a meaningful space where India's healthcare leaders, innovators, and policymakers can collaborate and co-create the future. In 2025, we are elevating that experience with new features, richer content, and stronger partnerships. With India's healthcare sector growing at an unprecedented pace, the time is ripe for a platform that goes beyond showcasing—one that actively shapes dialogue, policy, and real-world impact."
The India Health Exhibition 2025 is supported by industry bodies such as AIMED, ADMI, AHPI, EPCMD, and MTAI, ensuring it remains aligned with both sectoral priorities and the country’s broader goals under the ‘Make in India’ and ‘Digital Health Mission’ agendas.
For registration details and exhibitor information, visit www.indiahealth-exhibition.com
